Most Recent
ASIC's newly installed chief on Thursday slammed banks and other financial firms for their "trust deficit" and vowed to deploy "every inch of our powers and tools" to go after violators.
The Australian Competition and Consumer Commission has raised concerns that the proposed $2 billion acquisition of Sydney toll road WestConnex by toll road operator Transurban may stymie competition for toll road projects in Australia.
Optus was ordered Wednesday to temporarily pull an ad that Telstra alleges makes a false and damaging claim about the superiority of Optus' mobile network.
Construction, Forestry, Mining, and Energy Union bosses John Setka and Shaun Reardon have walked free from court after prosecutors on Wednesday dropped blackmail charges related to the union's boycott of Boral concrete.
The Federal Court has ordered appliance and furniture leasing company Radio Rentals to pay a $2 million penalty for failing to verify consumers' financial situations before signing them up for leases.
The Full Federal Court on Tuesday dismissed an appeal by aviation services company Aerocare of a ruling rejecting an enterprise agreement the Transport Workers Union called "substandard".
The financing arrangement underwriting Quinn Emanuel's shareholder class action against AMP, which will earn its partner Burford Capital a record low 10 percent of any recovery, sets a new standard in class action litigation funding, and is expected to spark greater price competition in the industry.
The Full Federal Court has slapped Japanese car parts maker Yazaki Corporation with a $46 million penalty for colluding with a competitor on prices for wire harnesses supplied to Toyota, handing a win to the ACCC which argued the original $9.5 million penalty handed down did not reflect the seriousness of the conduct.
Apple has lost its bid to be represented by an outside lawyer in an unfair dismissal dispute, with the Fair Work Commission saying Monday the case was not inherently complex and the company's inhouse legal counsel had time to bone up employment litigation.
Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to "tens of millions of dollars" in losses.